UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
October 28, 2015 (October 27, 2015)
Rite Aid Corporation
(Exact name of registrant as specified in its charter)
Delaware |
|
1-5742 |
|
23-1614034 |
(State or Other Jurisdiction |
|
(Commission File Number) |
|
(IRS Employer |
30 Hunter Lane, Camp Hill, Pennsylvania 17011
(Address of principal executive offices, including zip code)
(717) 761-2633
(Registrants telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
x Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On October 27, 2015, Rite Aid Corporation (Rite Aid) entered into an Agreement and Plan of Merger (the Merger Agreement) with Walgreens Boots Alliance, Inc., a Delaware corporation (Walgreens), and Victoria Merger Sub, Inc., a Delaware corporation and a wholly-owned direct subsidiary of Walgreens.
A copy of the press release is attached hereto as Exhibit 99.1, and is incorporated herein in its entirety by reference.
The information required by Item 1.01, including a copy of the Merger Agreement, will be filed in a separate Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99.1* |
|
Joint press release issued by Rite Aid and Walgreens, on October 27, 2015. |
Cautionary Statement Regarding Forward Looking Statements
This document includes forward-looking statements within the meaning of the securities laws. The words may, could, should, estimate, project, forecast, intend, expect, anticipate, believe, target, plan, providing guidance and similar expressions are intended to identify information that is not historical in nature.
This document contains forward-looking statements relating to the proposed transaction between Rite Aid and Walgreens pursuant to a merger. All statements, other than historical facts, including statements regarding the expected timing of the closing of the transaction; the ability of the parties to complete the transaction considering the various closing conditions; the expected benefits of the transaction such as improved operations, enhanced revenues and cash flow, growth potential, market profile and financial strength; the competitive ability and position of Walgreens following completion of the proposed transaction; and any assumptions underlying any of the foregoing, are forward-looking statements. Such statements are based upon current plans, estimates and expectations that are subject to risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. You should not place undue reliance on such statements. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, that (1) one or more closing conditions to the transaction, including certain regulatory approvals, may not be satisfied or waived, on a timely basis or otherwise, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the transaction, may require conditions, limitations or restrictions in connection with such approvals or that the required approval by the shareholders of each of Rite Aid and Walgreens may not be obtained; (2) there may be a material adverse change of Rite Aid or the business of Rite Aid may suffer as a result of uncertainty surrounding the transaction; (3) the transaction may involve unexpected costs, liabilities or delays; (4) legal proceedings may be initiated related to the transaction; (5) changes in economic conditions, political conditions, changes in federal or state laws or regulations, including the Patient Protection and Affordable Care Act and the Health Care Education Affordability Reconciliation Act and any regulations enacted thereunder may occur; (6) provider and state contract changes may occur; (7) reduction in provider payments by governmental payors may occur; (8) the expiration of Rite Aid or Walgreens Medicare or Medicaid managed care contracts by federal or state governments and tax matters; (8) there may be difficulties and delays in achieving synergies and cost savings; and (9) other risk factors as detailed from time to time in Rite Aids and Walgreens reports filed with the Securities and Exchange Commission (SEC), including Rite Aids Annual Report on Form 10-K for the year ended February 28, 2015 which is available on the SECs Web site (www.sec.gov). There can be no assurance that the merger will be completed, or if it is completed, that it will close within the anticipated time period or that the expected benefits of the merger will be realized.
Neither Rite Aid nor Walgreens undertakes any obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. Readers are cautioned not to place undue reliance on any of these forward-looking statements.
Additional Information and Where to Find It
In connection with the proposed strategic combination, Rite Aid intends to file relevant materials with the
* Furnished, not filed.
SEC, including a preliminary proxy statement on Schedule 14A. Following the filing of the definitive proxy statement with the SEC, Rite Aid will mail the definitive proxy statement and a proxy card to each stockholder entitled to vote at the special meeting relating to the proposed merger. INVESTORS ARE URGED TO READ THE PROXY STATEMENT WHEN IT BECOMES AVAILABLE BECAUSE IT WILL CONTAIN IMPORTANT INFORMATION. Investors will be able to obtain the proxy statement, as well as other filings containing information about Rite Aid, free of charge, from the SECs Web site (www.sec.gov). Investors may also obtain Rite Aids SEC filings in connection with the transaction, free of charge, from Rite Aids Web site (www.RiteAid.com) under the link Investor Relations and then under the tab SEC Filings, or by directing a request to Rite Aid, Matt Schroeder, Attention: Vice President, Investor Relations.
Participants in the Merger Solicitation
The directors, executive officers and employees of Rite Aid and other persons may be deemed to be participants in the solicitation of proxies in respect of the transaction. Information regarding Rite Aids directors and executive officers is available in its definitive proxy statement for its 2016 annual meeting of stockholders filed with the SEC on May 15, 2015. This document can be obtained free of charge from the sources indicated above. Other information regarding the interests of the participants in the proxy solicitation will be included in the proxy statement when it becomes available. This communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
RITE AID CORPORATION | ||
|
| ||
Dated: October 28, 2015 |
By: |
/s/ James J. Comitale | |
|
|
Name: |
James J. Comitale |
|
|
Title: |
Senior Vice President, General Counsel |
Exhibit 99.1
|
|
Walgreens Boots Alliance to Acquire Rite Aid for $17.2 Billion in All-Cash Transaction
· Acquisition furthers Walgreens Boots Alliances commitment to accessible, affordable, quality healthcare in the U.S. and advances consumer access to pharmacy-led health and wellbeing
· Acquisition underscores Walgreens Boots Alliances global approach to growth opportunities
· Rite Aid shareholders to receive $9.00 per share in cash, a premium of 48 percent to the closing price on 26 October 2015
· Transaction expected to be accretive to Walgreens Boots Alliances adjusted earnings per share in its first full year after completion
Deerfield, Ill. and Camp Hill, Penn., 27 October 2015 Walgreens Boots Alliance, Inc. (Nasdaq: WBA) and Rite Aid Corporation (NYSE: RAD) today announced that they have entered into a definitive agreement under which Walgreens Boots Alliance will acquire all outstanding shares of Rite Aid, a U.S. retail pharmacy chain, for $9.00 per share in cash, for a total enterprise value of approximately $17.2 billion, including acquired net debt. The purchase price represents a premium of 48 percent to the closing price per share on 26 October 2015, the day before the agreement was signed. The combination of Walgreens Boots Alliance and Rite Aid creates a further opportunity to deliver a high-quality retail pharmacy choice for U.S. consumers in an evolving and increasingly personalized healthcare environment.
Walgreens Boots Alliance is highly focused on building a differentiated in-store experience for health, wellness and beauty, and this combination will help accelerate Rite Aids own efforts toward that end. Once the acquisition closes, Walgreens Boots Alliance plans to further transform Rite Aids stores to better meet consumer needs.
Todays announcement is another step in Walgreens Boots Alliances global development and continues our profitable growth strategy. In both mature and newer markets across the world, our approach is to advance and broaden the delivery of retail health, wellbeing and beauty products and services, said Walgreens Boots Alliance Executive Vice Chairman and CEO Stefano Pessina. This combination will further strengthen our commitment to making quality healthcare accessible to more customers and patients. Our complementary retail pharmacy footprints in the U.S. will create an even better network, with more health and wellness solutions available in stores and online. Walgreens Boots Alliance will provide to Rite Aid its global expertise and resources to accelerate the delivery of integrated frontline care, and to offer innovative solutions for providers, payers and other entities in the U.S. healthcare system. Finally, this combination will generate a stronger base for sustainable growth and investment into Rite Aid stores, while realizing synergies over time.
Joining together with Walgreens Boots Alliance will enhance our ability to meet the health and wellness needs of Rite Aids customers while also delivering significant value to our shareholders, said Rite Aid Chairman and CEO John Standley. This transaction is a testament to the hard work of all our associates to deliver a higher level of care to the patients and communities we serve. Together with Walgreens Boots Alliance, the Rite Aid team can continue to build upon this great work through access to increased capital that will enhance our store base and expand opportunities as part of the first global pharmacy-led, health and wellbeing enterprise.
The boards of directors of both companies have approved the transaction, which is subject to approval by the holders of Rite Aids common stock, the expiration or termination of applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and other customary closing conditions. The transaction is expected to close in the second half of calendar 2016.
The transaction is expected to be accretive to Walgreens Boots Alliances adjusted earnings per share in its first full year after completion. Additionally, Walgreens Boots Alliance expects to realize synergies in excess of $1 billion.
Upon completion of the merger, Rite Aid will be a wholly owned subsidiary of Walgreens Boots Alliance, and is expected to initially operate under its existing brand name. Working together, decisions will be made over time regarding the integration of the two companies, ultimately creating a fully harmonized portfolio of stores and infrastructure.
Walgreens Boots Alliance expects to finance the transaction through a combination of existing cash, assumption of existing Rite Aid debt and issuance of new debt.
Citi acted as Rite Aids exclusive financial adviser, with Skadden, Arps, Slate, Meagher & Flom LLP acting as its legal counsel on transaction legal matters and Jones Day acting as its legal counsel on antitrust regulatory matters.
UBS Investment Bank acted as Walgreens Boots Alliances financial adviser and provided a fairness opinion to the board of directors of Walgreens Boots Alliance, with Simpson Thacher & Bartlett LLP acting as its legal counsel on transaction legal matters and Weil, Gotshal & Manges LLP acting as its legal counsel on antitrust regulatory matters. UBS Investment Bank will be the sole arranger on the bridge financing to Walgreens Boots Alliance.
Walgreens Boots Alliance will hold a one-hour conference call to discuss its fourth quarter results and todays acquisition announcement beginning at 8:30 a.m. Eastern time tomorrow, 28 October 2015. The conference call will be simulcast through the Walgreens Boots Alliance investor relations website at: http://investor.walgreensbootsalliance.com. A replay of the conference call will be archived on the website for 12 months after the call.
The replay also will be available from 11:30 a.m. Eastern time, 28 October 2015 through 4 November 2015, by calling 855-859-2056 within the USA and Canada, or 404-537-3406 outside the USA and Canada, using replay code 42212047.
ENDS
Notes to Editors:
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is the first global pharmacy-led, health and wellbeing enterprise.
The company was created through the combination of Walgreens and Alliance Boots in December 2014, bringing together two leading companies with iconic brands, complementary geographic footprints, shared values and a heritage of trusted health care services through pharmaceutical wholesaling and community pharmacy care, dating back more than 100 years.
The company employs more than 370,000* people and has a presence in more than 25* countries; it is the largest retail pharmacy, health and daily living destination in the USA and Europe. Including its equity method investments, Walgreens Boots Alliance is a global leader in pharmacy-led, health and wellbeing retail with over 13,100* stores in 11* countries. The company includes one of the largest global pharmaceutical wholesale and distribution networks with over 350* distribution centers delivering to more than 200,000** pharmacies, doctors, health centers and hospitals each year in 19* countries. In addition, Walgreens Boots Alliance is one of the worlds largest purchasers of prescription drugs and many other health and wellbeing products.
Its portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as increasingly global health and beauty product brands, such as No7, Botanics, Liz Earle and Soap & Glory. More company information is available at www.walgreensbootsalliance.com.
* As at 31 August 2015 including equity method investments
** For 12 months ended 31 August 2015 including equity method investments
Media Relations |
|
Contact |
USA / Michael Polzin |
|
+1 847 315 2935 |
International / Laura Vergani |
|
+44 (0)207 980 8585 |
|
|
|
Investor Relations |
|
Contact |
Gerald Gradwell and Ashish Kohli |
|
+1 847 315 2922 |
About Rite Aid
Rite Aid Corporation (NYSE: RAD) is one of the nations leading drugstore chains with nearly 4,600 stores in 31 states and the District of Columbia and fiscal 2015 annual revenues of $26.5 billion. Information about Rite Aid, including corporate background and press releases, is available through the companys website at www.riteaid.com.
Media Relations |
|
Contact |
Ashley Flower |
|
+1 717 975 5718 |
|
|
|
Investor Relations |
|
Contact |
Matt Schroeder |
|
+1 717 214 8867 |
Cautionary Note Regarding Forward Looking Statements
Certain statements in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as anticipate, believe, continue, could, estimate, expect, intend, may, plan, predict, project, should, and will and variations of such words and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including, but not limited to, risks related to the satisfaction of the conditions to closing the acquisition in the anticipated timeframe or at all, including risks related to the failure to obtain necessary regulatory and Rite Aid stockholder approvals and the possibility that the acquisition does not close, including in circumstances in which Rite Aid would be obligated to pay Walgreens Boots Alliance a termination fee or other expenses and vice versa; risks related to the ability to realize the anticipated benefits of the acquisition, including the possibility that the expected synergies from the proposed acquisition will not be realized or will not be realized within the expected time period; the risk that the businesses will not be integrated successfully; risks associated with the financing of the transaction; disruption from the transaction making it more difficult to maintain business and operational relationships; negative effects of this announcement or the consummation of the proposed acquisition on the market price of Walgreens Boots Alliances common stock; significant transaction costs; unknown liabilities; the risk of litigation and/or regulatory actions related to the proposed acquisition; other business effects, including the effects of industry, market, economic, political or regulatory conditions; future exchange or interest rates or credit ratings; changes in tax laws, regulations, rates and policies; competitive developments; and risks and uncertainties discussed in the reports that Walgreens Boots Alliance and Rite Aid have filed with the Securities and Exchange Commission (the SEC). Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Walgreens Boots Alliance and Rite Aid expressly disclaim any current intention to update publicly any forward-looking statement after the distribution of this release, whether as a result of new information, future events, changes in assumptions or otherwise. A further list and description of risks and uncertainties can be found in Rite Aids Annual Report on Form 10-K for the fiscal year ended February 28, 2015 and its reports on Form 10-Q and Form 8-K as well as Walgreens Boots Alliances most recent Form 10-K and its reports on Form 10-Q and Form 8-K. This release does not constitute an offer of any securities for sale.
Additional Information and Where to Find It
In connection with the proposed transaction, Rite Aid will file with the SEC and mail or otherwise provide to its stockholders a proxy statement regarding the proposed transaction. BEFORE MAKING ANY VOTING DECISION, RITE AIDS STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT IN ITS ENTIRETY WHEN IT BECOMES AVAILABLE AND ANY OTHER DOCUMENTS FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED MERGER OR INCORPORATED BY REFERENCE THEREIN BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND THE PARTIES TO THE PROPOSED TRANSACTION. Investors and security holders may obtain a free copy of the proxy statement and other documents that Rite Aid files with the SEC (when available) from the SECs website at www.sec.gov and Rite Aids website at www.riteaid.com.
Participants in Solicitation
Rite Aid and its directors, executive officers and employees may be deemed, under SEC rules, to be participants in the solicitation of proxies from Rite Aids stockholders with respect to the proposed acquisition. Information regarding the interests of such individuals in the proposed acquisition of Rite Aid by Walgreens Boots Alliance will be included in the proxy statement relating to such acquisition when it is filed with the SEC. You may obtain information about Rite Aids executive officers and directors in Rite Aids definitive proxy statement for its 2016 annual meeting of stockholders, which was filed with the SEC on May 15, 2015. These documents may be obtained free of charge from the SECs website at www.sec.gov and Rite Aids website at www.riteaid.com.
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end